CFO departure
Olenox Industries Inc. discloses CFO departure: Patricia Kaelin
Olenox Industries Inc. reported in a Form 8-K filed June 11, 2026 a change involving its Chief Financial Officer, Patricia Kaelin, effective June 5, 2026. The filing's own words are quoted below.
In the filing's words
On June 5, 2026, Olenox Industries, Inc. (the “Company”) informed Patricia Kaelin, Chief Financial Officer of the Company, of her dismissal from the Company, and the Company received a resignation letter back from her the same day. The Company has commenced its search for a replacement Chief Financial Officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Olenox Industries Inc. (OLOX) |
|---|---|
| Event | Departure |
| Outgoing | Patricia Kaelin |
| Effective | June 5, 2026 |
| 8-K filed | June 11, 2026 |
| SEC CIK | 0001023994 |
Olenox Industries Inc. reported this change in a Form 8-K, Item 5.02, filed June 11, 2026. The filing's own words are quoted above.
Before and after at Olenox Industries Inc.
The adjacent records in the company's seat timeline.
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Patricia Kaelin? Send a correction with the primary source.